Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Gainer SD"'
Autor:
Dovedi SJ; Early Oncology R&D, AstraZeneca, Cambridge, United Kingdom. simon.dovedi@astrazeneca.com yariv.mazor@astrazeneca.com., Elder MJ; Early Oncology R&D, AstraZeneca, Cambridge, United Kingdom., Yang C; Antibody Discovery and Protein Engineering, R&D, AstraZeneca, Gaithersburg, Maryland., Sitnikova SI; Early Oncology R&D, AstraZeneca, Cambridge, United Kingdom., Irving L; Antibody Discovery and Protein Engineering, R&D, AstraZeneca, Gaithersburg, Maryland., Hansen A; Translational Science and Experimental Medicine, Respiratory and Immunology (RI), Biopharmaceuticals R&D, AstraZeneca, Gaithersburg, Maryland., Hair J; Early Oncology R&D, AstraZeneca, Cambridge, United Kingdom., Jones DC; Early Oncology R&D, AstraZeneca, Cambridge, United Kingdom., Hasani S; Antibody Discovery and Protein Engineering, R&D, AstraZeneca, Gaithersburg, Maryland., Wang B; Antibody Discovery and Protein Engineering, R&D, AstraZeneca, Gaithersburg, Maryland., Im SA; Division of Hematology-Oncology, Department of Internal Medicine, Seoul National University Hospital, Seoul National University School of Medicine, Seoul, Korea., Tran B; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia., Subramaniam DS; Early Oncology R&D, AstraZeneca, Cambridge, United Kingdom., Gainer SD; Early Oncology R&D, AstraZeneca, Cambridge, United Kingdom., Vashisht K; Early Oncology R&D, AstraZeneca, Cambridge, United Kingdom., Lewis A; Early Oncology R&D, AstraZeneca, Cambridge, United Kingdom., Jin X; Antibody Discovery and Protein Engineering, R&D, AstraZeneca, Gaithersburg, Maryland., Kentner S; Early Oncology R&D, AstraZeneca, Cambridge, United Kingdom., Mulgrew K; Early Oncology R&D, AstraZeneca, Cambridge, United Kingdom., Wang Y; Early Oncology R&D, AstraZeneca, Cambridge, United Kingdom., Overstreet MG; Early Oncology R&D, AstraZeneca, Cambridge, United Kingdom., Dodgson J; Antibody Discovery and Protein Engineering, R&D, AstraZeneca, Gaithersburg, Maryland., Wu Y; Antibody Discovery and Protein Engineering, R&D, AstraZeneca, Gaithersburg, Maryland., Palazon A; Early Oncology R&D, AstraZeneca, Cambridge, United Kingdom., Morrow M; Early Oncology R&D, AstraZeneca, Cambridge, United Kingdom., Rainey GJ; Early Oncology R&D, AstraZeneca, Cambridge, United Kingdom., Browne GJ; Antibody Discovery and Protein Engineering, R&D, AstraZeneca, Gaithersburg, Maryland., Neal F; Antibody Discovery and Protein Engineering, R&D, AstraZeneca, Gaithersburg, Maryland., Murray TV; Antibody Discovery and Protein Engineering, R&D, AstraZeneca, Gaithersburg, Maryland., Toloczko AD; Antibody Discovery and Protein Engineering, R&D, AstraZeneca, Gaithersburg, Maryland., Dall'Acqua W; Antibody Discovery and Protein Engineering, R&D, AstraZeneca, Gaithersburg, Maryland., Achour I; Early Oncology R&D, AstraZeneca, Cambridge, United Kingdom., Freeman DJ; Early Oncology R&D, AstraZeneca, Cambridge, United Kingdom., Wilkinson RW; Early Oncology R&D, AstraZeneca, Cambridge, United Kingdom., Mazor Y; Antibody Discovery and Protein Engineering, R&D, AstraZeneca, Gaithersburg, Maryland. simon.dovedi@astrazeneca.com yariv.mazor@astrazeneca.com.
Publikováno v:
Cancer discovery [Cancer Discov] 2021 May; Vol. 11 (5), pp. 1100-1117. Date of Electronic Publication: 2021 Jan 08.
Autor:
Koch KM; GlaxoSmithKline, 5 Moore Dr, Research Triangle Park, NC, 27709, USA., Dees EC; GlaxoSmithKline, 5 Moore Dr, Research Triangle Park, NC, 27709, USA.; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, 27514, USA., Coker SA; GlaxoSmithKline, 5 Moore Dr, Research Triangle Park, NC, 27709, USA.; Section of Clinical Pharmacology and Hematology/Oncology, Department of Medicine, The Geisel School of Medicine at Dartmouth & The Norris Cotton Cancer Center at Dartmouth-Hitchcock Medical Center, One Medical Center Drive, Lebanon, NH, 03756, USA., Reddy NJ; GlaxoSmithKline, 5 Moore Dr, Research Triangle Park, NC, 27709, USA.; Section of Clinical Pharmacology and Hematology/Oncology, Department of Medicine, The Geisel School of Medicine at Dartmouth & The Norris Cotton Cancer Center at Dartmouth-Hitchcock Medical Center, One Medical Center Drive, Lebanon, NH, 03756, USA.; LGHP Hematology Oncology, 2102 Harrisburg Pike, Lancaster, PA, 17604, USA., Gainer SD; GlaxoSmithKline, 5 Moore Dr, Research Triangle Park, NC, 27709, USA., Arya N; GlaxoSmithKline, 5 Moore Dr, Research Triangle Park, NC, 27709, USA., Beelen AP; GlaxoSmithKline, 5 Moore Dr, Research Triangle Park, NC, 27709, USA.; G1 Therapeutics 4501 Research Commons, Suite 100, Research Triangle Park, NC, 27709, USA., Lewis LD; GlaxoSmithKline, 5 Moore Dr, Research Triangle Park, NC, 27709, USA. Lionel.D.Lewis@Dartmouth.edu.; Section of Clinical Pharmacology and Hematology/Oncology, Department of Medicine, The Geisel School of Medicine at Dartmouth & The Norris Cotton Cancer Center at Dartmouth-Hitchcock Medical Center, One Medical Center Drive, Lebanon, NH, 03756, USA. Lionel.D.Lewis@Dartmouth.edu.
Publikováno v:
Cancer chemotherapy and pharmacology [Cancer Chemother Pharmacol] 2017 Dec; Vol. 80 (6), pp. 1141-1146. Date of Electronic Publication: 2017 Nov 02.
Autor:
Burris HA 3rd; Sarah Cannon Research Institute, 250 25th Ave North, Suite 110, Nashville, TN 37203, USA. howard.burris@scresearch.net, Dowlati A, Moss RA, Infante JR, Jones SF, Spigel DR, Levinson KT, Lindquist D, Gainer SD, Dar MM, Suttle AB, Ball HA, Tan AR
Publikováno v:
Molecular cancer therapeutics [Mol Cancer Ther] 2012 Aug; Vol. 11 (8), pp. 1820-8. Date of Electronic Publication: 2012 Jun 07.
Autor:
Heath EI; Karmanos Cancer Institute, Department of Oncology, Wayne State University, Detroit, Michigan, USA. heathe@karmanos.org, Chiorean EG, Sweeney CJ, Hodge JP, Lager JJ, Forman K, Malburg L, Arumugham T, Dar MM, Suttle AB, Gainer SD, LoRusso P
Publikováno v:
Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2010 Dec; Vol. 88 (6), pp. 818-23. Date of Electronic Publication: 2010 Oct 27.
Autor:
Johnson BM; PhD 5 Moore Drive, Research Triangle Park, NC 27709, USA. Brendan.M.Johnson@GSK.com, Adams LM, Zhang K, Gainer SD, Kirby LC, Blum RA, Apseloff G, Morrison RA, Schutz RA, Lebowitz PF
Publikováno v:
Journal of clinical pharmacology [J Clin Pharmacol] 2010 Aug; Vol. 50 (8), pp. 951-9. Date of Electronic Publication: 2010 Feb 02.
Autor:
Tan AR; The Cancer Institute of New Jersey, New Brunswick, New Jersey 08903, USA. tanan@umdnj.edu, Dowlati A, Jones SF, Infante JR, Nishioka J, Fang L, Hodge JP, Gainer SD, Arumugham T, Suttle AB, Dar MM, Lager JJ, Burris HA 3rd
Publikováno v:
The oncologist [Oncologist] 2010; Vol. 15 (12), pp. 1253-61. Date of Electronic Publication: 2010 Dec 08.